Blueprint Investment Partners LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 57.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,302 shares of the healthcare conglomerate's stock after selling 1,756 shares during the period. Blueprint Investment Partners LLC's holdings in UnitedHealth Group were worth $659,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Howard Capital Management Group LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $341,000. Principal Financial Group Inc. raised its stake in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Thompson Siegel & Walmsley LLC increased its stake in UnitedHealth Group by 8.0% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 1,443 shares of the healthcare conglomerate's stock valued at $844,000 after buying an additional 107 shares during the period. Nwam LLC boosted its holdings in shares of UnitedHealth Group by 46.7% in the third quarter. Nwam LLC now owns 4,198 shares of the healthcare conglomerate's stock valued at $2,455,000 after acquiring an additional 1,336 shares in the last quarter. Finally, Stonebrook Private Inc. boosted its holdings in UnitedHealth Group by 111.8% in the 3rd quarter. Stonebrook Private Inc. now owns 5,453 shares of the healthcare conglomerate's stock valued at $3,188,000 after purchasing an additional 2,879 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
UNH stock traded down $2.92 during midday trading on Tuesday, hitting $513.58. 3,006,004 shares of the company traded hands, compared to its average volume of 4,898,654. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a 50 day simple moving average of $509.71 and a 200-day simple moving average of $546.15. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group's dividend payout ratio is currently 54.19%.
Analyst Ratings Changes
UNH has been the topic of a number of analyst reports. Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $629.32.
Check Out Our Latest Research Report on UnitedHealth Group
Insider Activity
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.